CAV1 deficiency significantly attenuated diabetes-induced myocardial hypertrophy, fibrosis, oxidative stress, and cardiomyocyte ferroptosis and improved cardiac dysfunction by activating the NRF2/GCLC signaling pathway. This evidence concerns the gene NFE2L2 and diabetes mellitus.